✦ LIBER ✦

ChemInform Abstract: Peptidomimetic Therapeutic Agents Targeting the Protease Enzyme of the Human Immunodeficiency Virus and Hepatitis C Virus

✍ Scribed by Youla S. Tsantrizos

Publisher: John Wiley and Sons
Year: 2009
Weight: 15 KB
Volume: 40
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200903249

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

📜 SIMILAR VOLUMES

Macrocyclic Inhibitors of the NS3 Protea

Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus Infection

✍ Youla S. Tsantrizos; Gordon Bolger; Pierre Bonneau; Dale R. Cameron; Nathalie Go 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB 👁 2 views

Macrocyclic Inhibitors of the NS3 Protea

Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus Infection

✍ Youla S. Tsantrizos; Gordon Bolger; Pierre Bonneau; Dale R. Cameron; Nathalie Go 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 2 views

Design and synthesis of substrate-based

Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere

✍ Yoshiaki Kiso 📂 Article 📅 1996 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 759 KB

## Peptidomimetic Human The human immunodeficiency virus (HIV) codas f o r an u.spartic protease known to be essential $)r retroviral mat urution and replicution. The H I V proteuw can rmignize Phe-Pro and Tyr-Pro sequences as the virus-specific cleuvuge site. These.fi.atures provided a basisJor th

Case report: Clearance of hepatitis C vi

Case report: Clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus

✍ Tomoyuki Endo; Katsuya Fujimoto; Mitsufumi Nishio; Satoshi Yamamoto; Masato Obar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## Abstract The effect of highly active antiretroviral therapy (HAART) on hepatitis C virus (HCV) infection remains uncertain. This report describes the case of a man with hemophilia with HIV–HCV coinfection with persistent disappearance of HCV RNA after changing the HAART regimen. He had been trea

ChemInform Abstract: Synthesis, Anti-Hum

ChemInform Abstract: Synthesis, Anti-Human Immunodeficiency Virus and Anti-Hepatitis B Virus Activities of Novel Oxaselenolane Nucleosides.

✍ J. DU; S. SURZHYKOV; J. S. LIN; M. G. NEWTON; Y.-C. CHENG; R. F. SCHINAZI; C. K. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 1 views

Occult hepatitis B virus infection in th

Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: Clinically relevant or a diagnostic problem?

✍ M. Rodríguez-Torres; J. Gonzalez-Garcia; N. Bräu; R. Solá; S. Moreno; J. Rockstr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

## Abstract The clinical relevance of occult hepatitis B virus (HBV) infection, defined as detectable HBV DNA serum/liver, in the absence of hepatitis B surface antigen (HBsAg), is unclear. We determined the prevalence of serum occult HBV infection in HIV/HCV co‐infected patients enrolled in APRICO